Conference
A phase III, intergroup, randomized, double-blind, chemoprevention trial of selenium (Se) supplementation in resected stage I non-small cell lung cancer (NSCLC)
Authors
Karp DD; Lee SJ; Wright GLS; Johnson DH; Johnston MR; Goodman GE; Clamon GH; Okawara GS; Marks R; Ruckdeschel JC
Volume
28
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
June 20, 2010
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
18
ISSN
0732-183X